Recruiting
Phase 1
Phase 2

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Sponsor:

Corbus Pharmaceuticals Inc.

Code:

NCT06265727

Conditions

Solid Tumor, Adult

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CRB-701

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information